关于食道癌中编程细胞死亡的知识地图:一个图书识别分析
Rulin Li1, Yanchun Yang1, Yang Gao1
1Department of Thoracic Surgery, Ziyang Central Hospital, Ziyang, 641300, China.
Discover oncology
|April 24, 2025
概括
关于食道癌中编程细胞死亡的研究正在迅速扩大,整合了多种细胞死亡途径. 国际合作和先进的战略是开发个性化癌症治疗的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 在食道癌症中,编程细胞死亡研究已经显著发展.
- 早期的研究集中在亡上,最近扩展到死亡,烧亡和铁亡.
研究的目的:
- 在食道癌中绘制编程细胞死亡的知识结构.
- 确定研究趋势,合作和未来方向.
主要方法:
- 从Web of Science核心收藏中对2677篇出版物 (2000-2024) 的图书统计分析.
- 利用CiteSpace,VOSviewer和文献计量器进行网络可视化和协作映射.
- 包括对食道癌症和各种编程细胞死亡途径 (亡,亡,烧亡,铁亡,自) 的研究.
主要成果:
- 出版物的显著增长,将重点转移到各种细胞死亡机制.
- 中国在产量和引用方面处于领先地位,在国际上有着强大的合作关系,包括美国和日本.
- 主要主题包括免疫瘤学,网络药理学和针对多个细胞死亡途径的翻译应用.
结论:
- 在食道癌中整合多种细胞死亡途径的多学科研究正在迅速扩大.
- 国际合作和先进的基因组学/免疫学策略将推动翻译的突破.
- 未来的研究有望为更多个性化和有效的食道癌治疗提供希望.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Barrett Esophagus-I: Introduction
1.5K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.5K


